Astrazeneca

FromAstraZeneca ([email protected])
Subject (44)Imfinzi improved DFS in early bladder cancer
Preheader (150)Imfinzi regimen demonstrated statistically significant and clinically meaningful improvement in disease-free survival for high-risk non-muscle-invasiv
Typography
Arial
Colors
Text Analysis
Body Words152
Subject Words7
Body Emojis1
Subject Emojis
Media Analysis
Text Links8
Image Links4
Total Links12
Images6
Technical Metrics
Performance
HTML Size, Kb
Pixel Length, px814 px
X-Spam Score0.7
Preheader OptimizedNo
Timing
Day of WeekWednesday
TimeEarly Morning

Imfinzi improved DFS in early bladder cancer

Imfinzi regimen demonstrated statistically significant and clinically meaningful improvement in disease-free survival for high-risk non-muscle-invasiv
Imfinzi improved DFS in early bladder cancer